05:05 PM EDT, 06/16/2025 (MT Newswires) -- David Krempa, Chief Business Officer, on June 12, 2025, sold 34,000 shares in Eton Pharmaceuticals ( ETON ) for $504,318. Following the Form 4 filing with the SEC, Krempa has control over a total of 612,646 common shares of the company, with 612,646 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1710340/000143774925020518/xslF345X05/rdgdoc.xml